Medical Devices: Page 16
-
Q&A
Nvidia’s David Niewolny on the future of AI in medical devices
Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for AI-enabled robotics, imaging and other features.
By Elise Reuter • June 2, 2025 -
Q&A
Beta Bionics CEO, CFO on how to take a company public
CEO Sean Saint and CFO Stephen Feider spoke about what’s different now that the company is public and the long journey of pursuing an IPO.
By Ricky Zipp • June 2, 2025 -
Explore the Trendlineâž”
Permission granted by Boston Scientific
TrendlineNew medical devices are reshaping the medtech industry
From pulsed field ablation devices to glucose sensors and surgical robotics, new medical technologies are transforming patient care and how people manage their health.
By MedTech Dive staff -
Bivacor wins FDA breakthrough nod for titanium total artificial heart
The company has so far treated patients who were weeks or months away from a transplant, but the device is theoretically suitable for longer-term use.
By Nick Paul Taylor • June 2, 2025 -
The medtech IPO window is finally open. Or is it?
After a three-year IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of activity.
By Ricky Zipp • Updated June 3, 2025 -
Boston Scientific plans changes to expected $200M tariff hit as situation shifts
The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.
By Nick Paul Taylor • May 29, 2025 -
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory requirements.”
By Elise Reuter • May 28, 2025 -
FDA finds Chinese lab copied or falsified data, endangering patients
The FDA said the findings raise doubts about the reliability and viability of premarket submissions based on the company’s data.
By Nick Paul Taylor • May 28, 2025 -
Abbott wins FDA approval for mitral valve replacement device, teeing up Edwards competition
Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired with MitraClip.
By Susan Kelly • May 28, 2025 -
Zimmer hires former Nevro CEO Kevin Thornal
Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.
By Susan Kelly • May 27, 2025 -
Trump calls for 50% tariffs on EU
The duties are slated to take effect July 9 as the bloc and the U.S. reengage on trade talks, the president said.
By Phil Neuffer • Updated May 27, 2025 -
BD recalls esophagogastric tubes linked to 2 serious injuries, 1 death
A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.
By Nick Paul Taylor • May 27, 2025 -
Stryker wins FDA clearance for minimally invasive back pain treatment
The company will compete with a device Boston Scientific acquired for $850 million.
By Nick Paul Taylor • May 22, 2025 -
Why Medtronic plans to spin out its diabetes business
While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on segments with higher margins.
By Elise Reuter • May 22, 2025 -
Trump tariffs
Cost cuts, production shifts: How medtech firms are managing tariffs
Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade standoff.
By Susan Kelly • May 22, 2025 -
Merit buys hemostatic device maker Biolife for $120M
Merit CEO Fred Lampropoulos said Biolife’s StatSeal and WoundSeal devices “address an estimated $350 million global market opportunity.”
By Nick Paul Taylor • May 21, 2025 -
AI in medtech is booming. Track new devices here.
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.
By Elise Reuter , Jasmine Ye Han • Updated Feb. 9, 2026 -
J&J subsidiary ordered to pay $147M for violating antitrust rules
A jury found that Biosense Webster withheld services to hospitals using reprocessed catheters.
By Elise Reuter • May 20, 2025 -
EndoQuest, Virtuoso begin clinical trials for surgical robots
EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed bladder lesion excision in six patients.
By Susan Kelly • May 19, 2025 -
US signals reciprocal tariffs will return for some countries
The White House will alert countries of their specific rates in the next two to three weeks, President Donald Trump said Friday.
By Phil Neuffer • Updated May 20, 2025 -
Sponsored by Paxxus
Beyond sterility: The quiet engineering challenge behind every safe medical device
Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient outcomes.
May 19, 2025 -
Deep Dive
House committees advance reconciliation text with big impacts on healthcare
Republicans in Energy and Commerce and Ways and Means have approved their portions of President Donald Trump’s “big, beautiful bill” after marathon markups. Here’s an extensive look at what the legislation means for healthcare.
By Rebecca Pifer Parduhn • May 16, 2025 -
Siemens Healthineers invests $150M in US, moves production from Mexico
News of the investment comes one week after Siemens Healthineers said tariffs will have a pretax impact of up to 300 million euros.
By Nick Paul Taylor • May 16, 2025 -
Intuitive CEO Gary Guthart to step down after 15 years
Dave Rosa, Intuitive Surgical’s president, takes over as chief executive, as the surgical robot maker accelerates the rollout of its latest da Vinci system.
By Susan Kelly • May 15, 2025 -
Trump tariffs
AdvaMed CEO Scott Whitaker pleads for tariff relief in Senate hearing
Whitaker repeated a call for “zero-for-zero” reciprocal tariffs between the U.S. and its trade partners in testimony before a Senate Finance Committee panel on critical supply chains.
By Susan Kelly • May 14, 2025 -
European Commission readies countermeasures to US tariffs
The commission is taking steps to target roughly $107 billion worth of imports if it can’t make a tariff deal with the U.S.
By Antone Gonsalves • May 14, 2025